FDA Inspection 1229084 — Corixa Corporation
The FDA completed an inspection of Corixa Corporation on February 9, 2024 in Marietta, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 9, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Marietta, PA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1270 | 21 CFR 211.68(b) | input/output verification |
| 2014 | 21 CFR 211.188(b)(2) | Identification of Equipment and Lines |
| 9225 | 21 CFR 606.171 | Biological product deviation report |